Douglas Eplett

Millennium Pharmacy Systems, Inc. Provides pharmaceutical management services. Its services include electronic order entry, medication and treatment administration, and management and reporting, in-house pharmacy, car coded med-pass packs, and pharmacy response. The firm also offers transition services such as data transfer, training, and installation and se-up. The company was founded by Gary Duty, Lena Sturgeon, and William J. Gatti in 2001 and is headquartered in Pittsburgh, PA.

The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA.

BreatheAmerica, Inc. provides services for health care management services. It offers its services in the areas of allergy tests, including skin tests, blood tests, and oral challenges; computerized tomography scans; endoscopy; immunotherapy; infusion therapy; and pulmonary functions. The company was founded by Ronald R. Charpentier, Joseph C. Hutts, Derril W. Reeves, Brook Bishop and David Hagaman in July 2007 and is headquartered in Franklin, TN.

Medtronic ATS Medical, Inc. develops, manufactures and markets medical devices for the treatment of structural heart disease. The company was founded on November 09, 2000 and is headquartered in Minneapolis, MN.

BehaVR LLC operates platform that provides virtual patient care experience services. The company was founded by Aaron Gani and is headquartered in Elizabethtown, KY.

Rinat Neuroscience Corp. manufactures and markets drugs for treating neurological diseases. The company was founded by Arnon Rosenthal and Patrick G. Lynn on November 21, 2000 and is headquartered in South San Francisco, CA.

Laboratoires Majorelle SAS operates as an independent French pharmaceutical company. Its products include Vitaros, Optilov, Keat range, and Carmex. The company was founded by Guillaume El Glaoui in 2012 and is headquartered in Paris, France.

Helen Keller International provides social services. It builds local capacity to combat blindness and malnutrition by establishing sustainable programs. The firm also provides scientific technical assistance, as well as research and data, to governments and international, regional, national, and local organizations to help expand current approaches and develop new ones. The company was founded by Helen Keller in 1915 and is headquartered in New York, NY.

Cadre Partners LLC (Cadre Partners) is a business advisory consultancy and private equity firm founded in 2011 by Marc Sandroff. The firm is headquartered in Arizona, United States.

Cave Creek Capital Management LLC (Cave Creek Capital Management) is a private equity firm founded in 2004 by G. Kevin Fechtmeyer. The firm is headquartered in Phoenix, Arizona.

Part of Walgreens Boots Alliance, Inc., C&M Pharmacy LLC is a pharmacy that is based in Glenview, IL. C&M Pharmacy was acquired by Walgreen Co. on July 05, 2006.

McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.

Founded in 2015, EUSA Pharma Holdco 1 (UK) Ltd. is a holding British company that operates subsidiaries which wholesale pharmaceutical products. The company is based in Hempstead, UK.

EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade.

Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY.

Part of Xanodyne Pharmaceuticals, Inc., Drug Enhancement Co of America LLC is a privately held product development organization dedicated to the creation of innovative healthcare technologies. The company is based in Union, KY. DECA's technologies are formulated by board certified pharmacologists and undergo rigorous safety, tolerability and efficacy testing and are then confirmed through IRB reviewed, human clinical trials. DECA has developed numerous platform technologies that have become cornerstone products for some highly successful companies including Richwood Pharmaceuticals, Integrity Pharmaceuticals, Xanodyne Pharmaceuticals, and the Union Springs family of companies (acquired by Enzymotec Ltd NASDAQ ENZY 2017). Once completed, the technology is professionally positioned to maximize valuation by strategic introduction into their commercialization network. The company was founded by Gilbert R. Gonzales. Drug Enhancement Co of America was acquired by Xanodyne Pharmacal, Inc. on January 07, 2002.

Clear Vascular, Inc. develops radionuclide products for multiple clinical applications. The firm has developed an injectable, targeted radiopharmaceutical agent, Tin-Annexin, for imaging and therapy of inflammatory tissues, initially targeting vulnerable and unstable plaque. It is a private radiopharmaceutical company developing a unique radionuclide for multiple clinical applications including diagnosis and therapy. The company was founded by Gilbert R. Gonzales in 2005 and is headquartered in Austin, TX.

Serene Medical, Inc. develops pharmaceutical and drug products. It targets overactive motor nerves. The company was founded by Gilbert R. Gonzales and Bankim Mehta in 2010 and is headquartered in Pleasanton, CA.

Part of Navidea Biopharmaceuticals, Inc., RHEUMCO LLC is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Dover, DE. The company was founded by Gilbert R. Gonzales.

Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom.

IPVALUE Management, Inc. provides strategic intellectual property consultation services. It specializes in IP rights licensing, technology transfer and enablement, spin-outs, and new venture formation. The company was founded by Peter Wheeler and Joseph J. Cote in 2001 and is headquartered in Santa Clara, CA.